keyword
https://read.qxmd.com/read/36925074/final-report-of-nrg-oncology-rtog-0022-a-phase-i-ii-study-of-conformal-and-intensity
#21
JOURNAL ARTICLE
Adam S Garden, Jonathan Harris, Avraham Eisbruch, K S Clifford Chao, William H Morrison, Paul M Harari, Todd Allen Swanson, Christopher U Jones, Sue S Yom, Sharon A Spencer, Rufus Scrimger, George Shenouda, Monica Shukla, Harold Y Lau, Michelle Mierzwa, Pedro Torres-Saavedra, Quynh Thu Le
BACKGROUND: XXXX XXXX XXXX XXXX (XXXX) XXXX was the first clinical trial evaluating multi-institution feasibility of IMRT for head and neck cancer. The primary endpoints of 2-year local-regional failure and reduction in acute xerostomia were reported previously. This report provides secondary endpoints with long-term follow-up. METHODS: Eligibility included patients diagnosed with T1-2, N0-1 oropharyngeal cancer. Secondary endpoints included disease control and overall survival...
March 14, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/36681089/radiotherapy-and-paclitaxel-plus-pazopanib-or-placebo-in-anaplastic-thyroid-cancer-nrg-rtog-0912-a-randomised-double-blind-placebo-controlled-multicentre-phase-2-trial
#22
RANDOMIZED CONTROLLED TRIAL
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, Shlomo A Koyfman, Michael F Dzeda, David A Clump, Saad A Khan, Manisha H Shah, Kevin Redmond, Pedro A Torres-Saavedra, Quynh-Thu Le, Nancy Y Lee
BACKGROUND: Anaplastic thyroid cancer is a rare and aggressive cancer with no standard radiotherapy-based local treatment. Based on data suggesting synergy between pazopanib and paclitaxel in anaplastic thyroid cancer, NRG Oncology did a double-blind, placebo-controlled, randomised phase 2 clinical trial comparing concurrent paclitaxel and intensity-modulated radiotherapy (IMRT) with the addition of pazopanib or placebo with the aim of improving overall survival in this patient population...
February 2023: Lancet Oncology
https://read.qxmd.com/read/36395794/tinkering-with-the-fit
#23
EDITORIAL
Sue S Yom
No abstract text is available yet for this article.
December 1, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/36244386/the-oligometastatic-state-balancing-between-cure-and-palliation
#24
EDITORIAL
Salma K Jabbour, Sue S Yom
No abstract text is available yet for this article.
November 15, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/36215572/-18-f-fdg-pet-ct-prediction-of-treatment-outcomes-in-hpv-positive-locally-advanced-oropharyngeal-cancer-receiving-de-intensified-therapy-results-from-nrg-hn002
#25
JOURNAL ARTICLE
Rathan M Subramaniam, Lyudmila DeMora, Min Yao, Sue S Yom, Maura Gillison, Jimmy J Caudell, John Waldron, Ping Xia, Christine Chung, Minh Tam Truong, Michelle Echevarria, Jason W Chan, Jessica L Geiger, Loren Mell, Samantha Seaward, Wade L Thorstad, Jonathan Jay Beitler, Khalil Sultanem, Diagjin Blakaj, Quynh-Thu Le
Objective: To determine the negative predictive value (NPV) of a 12-14 week post-treatment PET/CT for 2-year progression-free survival (PFS) and locoregional control (LRC) in patients with p16-positive locoregionally advanced oropharyngeal cancer (LA-OPC). Study was a secondary endpoint in NRG-HN002, a non-comparative phase II trial in p16-positive LA-OPC, stage T1-T2, N1-N2b or T3, N0-N2b (AJCC, 7th ed.) and ≤ 10 pack-year smoking. Patients were randomized in a 1:1 ratio to reduced-dose IMRT with or without cisplatin...
September 2, 2022: Journal of Nuclear Medicine
https://read.qxmd.com/read/36054296/longitudinal-analysis-of-swallowing-displacement-kinematics-after-oropharyngeal-cancer-treatment
#26
JOURNAL ARTICLE
Joseph Kidane, Joey Laus, Arushi Gulati, Grant E Gochman, Sarah L Schneider, Jason W Chan, Sue S Yom, Patrick Ha, W John Boscardin, William R Ryan, Yue Ma
BACKGROUND/OBJECTIVE: Quantitative swallowing displacement kinematics evolve in patients treated for oropharyngeal squamous cell carcinoma (OPSCC). We aimed to longitudinally assess these measurements and correlate them with functional swallowing outcomes. METHOD: A retrospective review was conducted on patients with OPSCC treated with definitive (chemo)radiation ([C]RT) or surgery with adjuvant (chemo)radiation (S-[C]RT) who completed at least two videofluoroscopic swallow studies (VFSS)...
August 29, 2022: Laryngoscope
https://read.qxmd.com/read/36053203/clinical-trial-development-in-tp53-mutated-locally-advanced-and-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma
#27
JOURNAL ARTICLE
Cristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, Barbara Burtness, Christine H Chung, Curtis R Pickering, Carole Fakhry, Quynh Thu Le, Sue S Yom, Thomas J Galloway, Erica Golemis, Alice Li, Jeffrey Shoop, Stuart Wong, Ranee Mehra, Heath Skinner, Nabil F Saba, Elsa R Flores, Jeffrey N Myers, James M Ford, Rachel Karchin, Robert L Ferris, Charles Kunos, Jean M Lynn, Shakun Malik
TP53 mutation is the most frequent genetic event in head and neck squamous cell carcinoma (HNSCC), found in over 80% of patients with HPV-negative disease. As mutations in the TP53 gene are associated with worse outcomes in HNSCC, novel therapeutic approaches are needed for patients with TP53 mutated tumors. The National Cancer Institute (NCI) sponsored a Clinical Trials Planning Meeting (CTPM) to address the issues of identifying and developing clinical trials for patients with TP53 mutations. Subcommittees, or Breakout Groups, were tasked with developing clinical studies in both the locally advanced and recurrent/metastatic disease settings as well consider signal seeking trial designs...
September 2, 2022: Journal of the National Cancer Institute
https://read.qxmd.com/read/35964622/the-top-circulated-red-journal-articles-from-2021-views-citations-tweets-downloads-and-shares
#28
EDITORIAL
Sue S Yom
No abstract text is available yet for this article.
September 1, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/35737362/environmental-outcomes-associated-with-transition-from-in-person-to-a-virtual-oncology-conference-during-the-covid-19-pandemic
#29
JOURNAL ARTICLE
Katie E Lichter, Taylor Drew, Sasha Demeulenaere, Emily Wong, Osama Mohamad, Sue S Yom, Hilary P Bagshaw
No abstract text is available yet for this article.
June 23, 2022: JAMA Oncology
https://read.qxmd.com/read/35715306/feasibility-of-accelerated-image-guided-high-dose-rate-interstitial-brachytherapy-with-inverse-planning-simulated-annealing-ipsa-hdrbt-for-post-operative-treatment-of-pathologically-node-negative-squamous-cell-carcinomas-of-the-oral-tongue
#30
JOURNAL ARTICLE
Christopher K Cheung, Jessica Chew, Katherine Wai, Sarah M Calkins, Patrick K Ha, William R Ryan, Adam Cunha, Sue S Yom, I-Chow Hsu, Jason W Chan
PURPOSE: Inverse planning simulated annealing (IPSA) produces highly conformal dose distributions and quick optimizations for high-dose-rate interstitial brachytherapy (HDRBT). We report our dosimetry and overall outcomes using this approach for the accelerated post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue (OTSCC) with high risk of local recurrence. METHODS: Patients with newly diagnosed pN0 OTSCC treated with partial glossectomy, neck dissection, and post-operative HDRBT alone from 2007 to 2021 were retrospectively reviewed...
2022: Brachytherapy
https://read.qxmd.com/read/35667551/consensus-quality-measures-and-dose-constraints-for-head-and-neck-cancer-with-an-emphasis-on-oropharyngeal-and-laryngeal-cancer-from-the-veterans-affairs-radiation-oncology-quality-surveillance-program-and-american-society-for-radiation-oncology-expert-panel
#31
JOURNAL ARTICLE
Evangelia Katsoulakis, Randi Kudner, Christina Chapman, John Park, Lindsay Puckett, Abhi Solanki, Rishabh Kapoor, Michael Hagan, Maria Kelly, Jatinder Palta, Roy Tishler, Ying Hitchcock, Bhisham Chera, Vladimir Feygelman, Gary Walker, David Sher, Ksenija Kujundzic, Emily Wilson, Samantha Dawes, Sue S Yom, Louis Harrison
PURPOSE: Safeguarding high-quality care using evidence-based radiation therapy for patients with head and neck cancer is crucial to improving oncologic outcomes, including survival and quality of life. METHODS AND MATERIALS: The Veterans Administration (VA) National Radiation Oncology Program established the VA Radiation Oncology Quality Surveillance Program (VAROQS) to develop clinical quality measures (QM) in head and neck cancer. As part of the development of QM, the VA commissioned, along with the American Society for Radiation Oncology, a blue-ribbon panel comprising experts in head and neck cancer, to develop QM...
2022: Practical Radiation Oncology
https://read.qxmd.com/read/35659598/diving-into-the-wreck-to-search-for-the-thing-itself
#32
JOURNAL ARTICLE
Sue S Yom
This article provides historical context, scansion, and interpretation of Adrienne Rich's poem Diving into the Wreck.
June 1, 2022: Practical Radiation Oncology
https://read.qxmd.com/read/35569468/the-red-journal-outstanding-reviewer-awards-for-2021
#33
JOURNAL ARTICLE
Sue S Yom
No abstract text is available yet for this article.
June 1, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/35427541/evaluating-the-generalizability-and-reproducibility-of-scientific-research
#34
EDITORIAL
Sue S Yom, Curtiland Deville, Marjan Boerma, David Carlson, Salma K Jabbour, Lisa Braverman
No abstract text is available yet for this article.
May 1, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/35417903/improved-accuracy-of-relative-electron-density-and-proton-stopping-power-ratio-through-cyclegan-machine-learning
#35
JOURNAL ARTICLE
Jessica E Scholey, Luciano Vinas, Vasant P Kearney, Sue S Yom, Peder E Z Larson, Martina Descovich, Atchar Sudhyadhom
PURPOSE: Kilovoltage computed tomography (kVCT) is the cornerstone of radiotherapy treatment planning for delineating tissues and towards dose calculation. For the former, kVCT provides excellent contrast and signal-to-noise ratio. For the latter, kVCT may have greater uncertainty in determining relative electron density (ρ_e) and proton stopping power ratio (SPR). Conversely, megavoltage CT (MVCT) may result in superior dose calculation accuracy. The purpose of this work was to convert kVCT HU to MVCT HU using deep learning to obtain higher accuracy ρ_e and SPR...
April 13, 2022: Physics in Medicine and Biology
https://read.qxmd.com/read/35398456/retreatment-of-recurrent-or-second-primary-head-and-neck-cancer-after-prior-radiation-executive-summary-of-the-american-radium-society-appropriate-use-criteria
#36
REVIEW
Matthew C Ward, Shlomo A Koyfman, Richard L Bakst, Danielle N Margalit, Beth M Beadle, Jonathan J Beitler, Steven Shih-Wei Chang, Jay S Cooper, Thomas J Galloway, John A Ridge, Jared R Robbins, Assuntina G Sacco, C Jillian Tsai, Sue S Yom, Farzan Siddiqui
Retreatment of recurrent or second primary head and neck cancers occurring in a previously irradiated field is complex. Few guidelines exist to support practice. We performed an updated literature search of peer-reviewed journals in a systematic fashion. Search terms, key questions, and associated clinical case variants were formed by panel consensus. The literature search informed the committee during a blinded vote on the appropriateness of treatment options via the modified Delphi method. The final number of citations retained for review was 274...
July 15, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/35387423/artificial-intelligence-guided-prediction-of-dental-doses-before-planning-of-radiation-therapy-for-oropharyngeal-cancer-technical-development-and-initial-feasibility-of-implementation
#37
JOURNAL ARTICLE
Jason W Chan, Nicole Hohenstein, Colin Carpenter, Adam J Pattison, Olivier Morin, Gilmer Valdes, Maria Thompson, Jennifer Perkins, Timothy D Solberg, Sue S Yom
Purpose: The aim was to develop a novel artificial intelligence (AI)-guided clinical decision support system, to predict radiation doses to subsites of the mandible using diagnostic computed tomography scans acquired before any planning of head and neck radiation therapy (RT). Methods and Materials: A dose classifier was trained using RT plans from 86 patients with oropharyngeal cancer; the test set consisted of an additional 20 plans. The classifier was trained to predict whether mandible subsites would receive a mean dose >50 Gy...
March 2022: Advances in Radiation Oncology
https://read.qxmd.com/read/35139735/international-assessment-of-interobserver-reproducibility-of-flap-delineation-in-head-and-neck-carcinoma
#38
JOURNAL ARTICLE
Arnaud Beddok, Leslie Guzene, Alexandre Coutte, David Thomson, Sue S Yom, Valentin Calugaru, Eivind Blais, Olivier Gilliot, Séverine Racadot, Yoann Pointreau, June Corry, Kenneth Jensen, Sandro Porceddu, Nazim Khalladi, Vianney Bastit, Audrey Lasne-Cardon, Pierre-Yves Marcy, Florent Carsuzaa, Christophe Nioche, Jean Bourhis, Julia Salleron, Juliette Thariat
Background: Several reports have suggested that radiotherapy after reconstructive surgery for head and neck cancer (HNC), could have deleterious effects on the flaps with respect to functional outcomes. To predict and prevent toxicities, flap delineation should be accurate and reproducible. The objective of the present study was to evaluate the interobserver variability of frequent types of flaps used in HNC, based on the recent GORTEC atlas. Materials and methods: Each member of an international working group (WG) consisting of 14 experts delineated the flaps on a CT set from six patients...
June 2022: Acta Oncologica
https://read.qxmd.com/read/35121948/an-artificial-intelligence-framework-integrating-longitudinal-electronic-health-records-with-real-world-data-enables-continuous-pan-cancer-prognostication
#39
JOURNAL ARTICLE
Olivier Morin, Martin Vallières, Steve Braunstein, Jorge Barrios Ginart, Taman Upadhaya, Henry C Woodruff, Alex Zwanenburg, Avishek Chatterjee, Javier E Villanueva-Meyer, Gilmer Valdes, William Chen, Julian C Hong, Sue S Yom, Timothy D Solberg, Steffen Löck, Jan Seuntjens, Catherine Park, Philippe Lambin
Despite widespread adoption of electronic health records (EHRs), most hospitals are not ready to implement data science research in the clinical pipelines. Here, we develop MEDomics, a continuously learning infrastructure through which multimodal health data are systematically organized and data quality is assessed with the goal of applying artificial intelligence for individual prognosis. Using this framework, currently composed of thousands of individuals with cancer and millions of data points over a decade of data recording, we demonstrate prognostic utility of this framework in oncology...
July 2021: Nature Cancer
https://read.qxmd.com/read/35022323/validation-of-anti-correlated-tgf%C3%AE-signaling-and-alternative-end-joining-dna-repair-signatures-that-predict-response-to-genotoxic-cancer-therapy
#40
JOURNAL ARTICLE
Ines Guix, Qi Liu, Miguel Angel Pujana, Patrick Ha, Josep Piulats, Isabel Linares, Ferran Guedea, Jian-Hua Mao, Ann Lazar, Jocelyn Chapman, Sue S Yom, Alan Ashworth, Mary Helen Barcellos-Hoff
PURPOSE: Loss of transforming growth factor β (TGFβ) signaling increases error-prone alternative end-joining (alt-EJ) DNA repair. We previously translated this mechanistic relationship as TGFβ and alt-EJ gene expression signatures, which are anti-correlated across cancer types. A score, βAlt, representing anti-correlation predicts patient outcome in response to genotoxic therapy. Here we sought to verify this biology in live specimens and additional datasets. EXPERIMENTAL DESIGN: Human head and neck squamous cell (HNSC) carcinoma explants were treated in vitro to test whether the signatures report TGFβ signaling, indicated by SMAD2 phosphorylation, and unrepaired DNA damage, indicated by persistent 53BP1 foci after irradiation or olaparib...
January 12, 2022: Clinical Cancer Research
keyword
keyword
112285
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.